CEACAM5 and colorectal carcinoma: Herein, we present the potential role of F. nucleatum in CRC screening and develop a combined biomarker model using F. nucleatum with other fecal‐/blood‐based markers including FOB, TRF, CEA, and CA19‐9, as well as personal characteristics including gender and age.